170 related articles for article (PubMed ID: 34422649)
1. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
Front Oncol; 2021; 11():696147. PubMed ID: 34422649
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
Jahr G; Broi MD; Holte H; Beiske K; Meling TR
Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
[TBL] [Abstract][Full Text] [Related]
6. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
7. Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.
Feng Y; Liu Y; Zhong M; Wang L
Front Oncol; 2021; 11():618694. PubMed ID: 33842320
[TBL] [Abstract][Full Text] [Related]
8. Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India.
Das S; Bagal B; Jain H; Kashyap L; Anbarasan S; Abhishek S; Bondili S; Nayak L; Thorat J; Mirgh S; Gokarn A; Punatar S; Ayushi S; Epari S; Tembhare P; Shetty P; Khanna N; Goda J; Aliasgar M; Gupta T; Sengar M; Khattry N; Laskar S; Menon H
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):57-70. PubMed ID: 36699441
[TBL] [Abstract][Full Text] [Related]
9. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
[TBL] [Abstract][Full Text] [Related]
10. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.
Luo Q; Yang C; Fu C; Wu W; Wei Y; Zou L
Front Oncol; 2021; 11():639644. PubMed ID: 33996552
[No Abstract] [Full Text] [Related]
12. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
[TBL] [Abstract][Full Text] [Related]
14. A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
Jang JE; Kim YR; Kim SJ; Cho H; Chung H; Lee JY; Park H; Kim Y; Cheong JW; Min YH; Kim JS
Eur J Cancer; 2016 Apr; 57():127-35. PubMed ID: 26918738
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.
Jung J; Lee H; Yun T; Lee E; Moon H; Joo J; Park WS; Choi M; Lee JO; Lee JS; Eom HS
Oncotarget; 2017 Sep; 8(43):74975-74986. PubMed ID: 29088839
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
Da Broi M; Jahr G; Beiske K; Holte H; Meling TR
Blood Cells Mol Dis; 2018 Nov; 73():25-32. PubMed ID: 30217760
[TBL] [Abstract][Full Text] [Related]
17. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
[TBL] [Abstract][Full Text] [Related]
18. Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.
Li T; Li H; Xie S; Tan Y; Xie ZP; Li WY; Ai F
Pathol Oncol Res; 2020 Apr; 26(2):1319-1324. PubMed ID: 31388933
[TBL] [Abstract][Full Text] [Related]
19. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.
Baek DW; Cho HJ; Bae JH; Sohn SK; Moon JH
Blood Res; 2020 Jun; 55(2):99-106. PubMed ID: 32408414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
